KATHLEEN BRUNO: Open Payments
NPI 1356757363 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 49 payments from 16 companies in 2025. Trend: 2023 $457 · 2024 $866 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $204 |
| ABBVIE INC. | 8 | $188 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Amgen Inc. | 4 | $59 |
| Lilly USA, LLC | 3 | $58 |
| Novo Nordisk Inc | 3 | $43 |
| SANOFI PASTEUR INC. | 2 | $34 |
| PFIZER INC. | 2 | $29 |
Products named: AIRSUPRA, VRAYLAR, CAPLYTA, GARDASIL 9, SHINGRIX, OTEZLA, TRELEGY ELLIPTA, KISUNLA.
Industry payments across AZ — which companies pay providers there.
